SUMMARY Jejunoileal bypass (JIB) has been widely used to treat patients with morbid obesity for the past 20 years. In rats JIB causes adaptive colonic hyperplasia and enhances colorectal neoplasia. In this study crypt cell production rate (CCPR) was measured stathmokinetically in cultured rectal biopsies from nine patients with JIB and seven controls without intestinal operations or disease. Crypt cell production rate in the group with JIB was more than double that of controls (12.80 (2.67) v 6.23 (1.49) cells/crypt/h: p<0001). There were no significant differences in crypt morphometry and histological examination of rectal biopsies was normal. Patients with JIB have a marked and persistent increase in cell proliferation in the large intestine and may be at increased risk of developing colonic cancer.
During the 20 years since jejunoileal bypass (JIB) was introduced for the treatment of morbid obesity,' it is estimated that over 100 000 such operations have been carried out in the USA alone.2 In rats, end-toside JIB stimulates adaptive growth and enhances chemical carcinogenesis in the colon,3 although extreme weight loss can limit these effects. 4 Similar phenomena in man would place a large group of young patients at increased risk of developing colorectal carcinoma, even if insufficient time has yet elapsed to reveal the threat. The operation probably reached its peak of popularity in the late 1970s. To date at least two patients have been reported with subsequent colorectal neoplasia: one developed a carcinoma' and the other two tubulovillous adenomas.6
As experimental hyperplasia precedes and predisposes to neoplasia in the large intestine,7 we have looked for evidence of permanent adaptation in the rectum of patients with previous JIB. The technique has involved measuring crypt cell production in mucosal biopsies maintained in short term organ culture. In the pilot experiment rectal biopsies from two controls and one patient with JIB were cultured over 24 hours in order to determine the optimum length of culture before measuring CCPR. Vincristine (0.6 [sg/ ml) was added to successive wells at three hour intervals from three to 21 hours of culture. Specimens were removed three hours after first exposure to vincristine, and the mean number of metaphase arrests/crypt at each sampling time was determined as previously described. CRYPT 
MORPHOMETRY
In four controls and five patients with JIB a modular image analysing system (Kontron MOP/AMO2), consisting of a glass evaluating tablet and a stylus linked to a microcomputer, was used to measure the crypt width and crypt area in 30 crypts per specimen." Camera lucida drawings were made of the microdissected crypts using a Leitz Dialux 2OEB light microscope with a drawing tube attachment, and measurements were made on the evaluating tablet.
HISTOLOGY
Five micron sections were cut from the biopsies before and after the period of organ culture. Slides CCPR=crypt cell production rate (cells/crypt/hour). Crypt cell production rate changes of similar magnitude were seen in the colon of rats killed six months after an equivalent JIB.3 The extent of the response in man is remarkable, because the rectum (not the colon) was sampled and adaptation is maximal immediately adjacent to the missing segment of bowel.7 Modest increments in the width and surface area of crypts did not attain statistical significance, probably because of the small numbers sampled in this part of the experiment. The mechanism of colonic hyperplasia after JIB has not been established. The marked increase in frequency of bowel actions may reflect greater amounts of irritative bile salts reaching the colon because of the short length of small bowel remaining in continuity. Biliary (and pancreatic) secretions are trophic,'2 mitogenic,'' and carcinogenic'4 to colonic mucosa. Humoral stimuli are a less likely explanation. Enteroglucagon concentrations rise by 1600% after JIB'`and might contribute to the postoperative hyperplasia in the residual functioning small bowel,'6 but enteroglucagon probably does not modulate colonic adaptation.7 Certainly raised concentrations of circulating enteroglucagon did nothing to overcome the inhibitory effects of colonic defunction on cell kinetics and carcinogenesis in our recent experiment. 18
In experimental animals the mucosal hyperplasia that follows JIB is a potent promoter of colorectal carcinogenesis.1 Could the same hold true in man?
In support, we have used organ culture to show increased CCPR in rectal biopsies of patients with active ulcerative proctocolitis, a known premalignant condition.'" Moreover these increments were more modest than those observed after JIB (40% v 105%), although they were still detectable in quiescent bowel. Against an increased risk of cancer is the profound weight reduction achieved after a successful JIB. Data from the American Cancer Society indicate that colorectal carcinoma (like many cancers) is more common in the obese and less common in those who are underweight.2"' Patients with a JIB also eat less after the operation,2' and the reduction in luminal contents would be expected to cause relative colonic hypoplasia;22 the type of food ingested might also change substantially. In rats a 99% JIB causes such extreme weight loss that the cocarcinogenic effect of the operation is lost. 4 In man the stimulatory effect of postoperative hyperplasia on 'spontaneous' carcinogenesis could be balanced by the inhibitory effects of weight loss and altered diet. It is reassuring to note that no evidence of colonic dysplasia could be found in a recent report of 38 patients studied at a mean of 11-5 years after JIB for morbid obesity.5 Nevertheless we believe that it is premature to discount the longterm risk of colorectal cancer, and patients with JIB should be kept under surveillance indefinitely.
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